MedWatch
Pharma & biotech

Novo Nordisk and Novartis will participate in large Danish project on decentralized clinical trials

A consortium of industry players has pooled over DKK 48m (USD 6.2m) to develop a digital platform meant to help recruit patients, collect data, and make it easier to conduct clinical studies – digitally.
A new project with a budget of DKK 48.2m will develop a platform of three apps to collect patient data with severe obesity, diabetic foot ulcers, and urticaria | Photo: Thomas Peter/Reuters/Ritzau Scanpix
A new project with a budget of DKK 48.2m will develop a platform of three apps to collect patient data with severe obesity, diabetic foot ulcers, and urticaria | Photo: Thomas Peter/Reuters/Ritzau Scanpix
by albert rønning-andersson, translated by daniel pedersen

Novo Nordisk, Novartis, and Monsenso. The Innovation Fund Denmark and Danish Life science Cluster. Universities, hospitals, and municipalities.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Related articles:

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading

Jobs

See all jobs